基因總覽
SCN5A 是蛋白質編碼基因,產物為 sodium voltage-gated channel alpha subunit 5,亦即 Nav1.5 的 α 次單元。它屬於 sodium channel 家族中的 Nav1.5/SCN5A 次家族,構成電壓閘控鈉離子通道的孔道部分。這種多次穿膜蛋白具有大型胞質區及跨膜區域,跨膜區依序組成四個重複單元;其整體架構使通道能在細胞膜上形成選擇性離子通路。
基因異名與舊稱
異名取自 HGNC,可能包含歷史名稱;蛋白質名稱以 UniProt 註解為準。
染色體位置與基因結構
查看實際轉錄本與 exon 註解
| Transcript | Genomic coordinates | Exons |
|---|---|---|
| ENST00000423572 ★ | 38,548,062–38,649,687 | 28 |
| ENST00000414099 | 38,548,057–38,633,349 | 26 |
| ENST00000327956 | 38,548,057–38,645,776 | 28 |
| ENST00000333535 | 38,548,057–38,649,691 | 28 |
| ENST00000455624 | 38,548,057–38,633,349 | 27 |
| ENST00000450102 | 38,548,057–38,633,349 | 26 |
| ENST00000970295 | 38,548,057–38,649,691 | 26 |
| ENST00001142647 | 38,548,057–38,649,691 | 28 |
| ENST00001142648 | 38,548,057–38,649,691 | 28 |
| ENST00000413689 | 38,548,062–38,649,687 | 28 |
| ENST00000449557 | 38,550,321–38,633,316 | 26 |
| ENST00001109839 | 38,603,210–38,649,691 | 12 |
顯示 12/14 個蛋白質編碼轉錄本;canonical 優先。
帶型與著絲點依 Ensembl 座標繪製;核染色體長度以 GRCh38 第 1 號染色體為共同尺度。黃色標記表示本基因位置,細小區間加粗以利辨識;實際基因長度與 exon 見下方資料。
分子功能與生物學過程
Nav1.5 是電壓閘控鈉離子通道的孔道形成次單元,直接參與興奮性細胞膜動作電位的去極化階段。通道會依細胞膜兩側的電位差,在關閉與開啟構形間切換;開啟時,Na(+) 可沿電化學梯度選擇性通過孔道。鈉離子流入使膜電位去極化,並由此啟動電訊號在細胞與組織中的傳播。
在心肌細胞中,Nav1.5 是主要表現的鈉離子通道,負責心臟動作電位的初始上升相,因而參與心跳的啟動。這項作用連結了離子跨膜流動與心肌電活動的起始;來源亦指出,Na(+) 的流動方向符合由細胞外進入細胞內的描述。
SCN5A 產物也與心臟正常電傳導及動作電位構形相關。它與 XIRP2 的交互作用被描述為維持正常心臟動作電位構形所需,並與心室傳導系統中希氏束以下部分的形成有關。此處與 XIRP2 相關的功能標註為相似性推論,因此不應視為已在此條目中直接證實的機制。
Promoter 與基因調控
>SCN5A ENST00000423572 GRCh38 chr3:38649587-38650687 strand=-1 5′→3′ 相對 TSS:-1000 到 +100 bp;1101 bp 依轉錄本 TSS 擷取的基因組序列;TSS = 0,兩端包含,未驗證為 promoter GAGAAACAGTGGGTGTGTAAGTATGTGACTCCAGGCTCTGCATGTGTCAAGGTGAAGGTTGTATGTGGCT CAAGAGGGTGGAAGTATATATATAAAGAGGTATATACATGTATATATATGTATGTGTGTGTGTGTGTTTG CGCGCGCGCGTGTGTGGGTGTCTCTGTGTTGGTTGCCTGCTTGCTTCTGGGTCTGGGTGTGTGTTTGGTT CTGTCAGCATGTGCGTCCGTGTGTTCAGGTAGATGTGTACCATTGTGCAGATTTCTGTGGCATCACTAAG TGTGTCTCCAGGAAAGTGTGGTTCGAGTGAGTGTGTGTGTCTCTGTGTCAGTGTGTCAGTGGATGTGTGT CTAAGTCATGTGGGTGTCTAAGTTTGTCAGAGTGTCTTCCTCAGTGTCAGTGTGTGTCAATGATGTGTCT GTCTGTGTCTGTGTGGGTGTGTGGGGGTGTGTATCTGTCTCAGGGTGCATGTGTGTGTCTGTGTCAGTGC AGGTATGCCTATGGCAGCGTGTGTCTGTCTCGGCATGAGTGTCAGTGTATGCCCGTGTCCACGTGGGTGG GTGGGTGTCTGGTAGCCTTCCCAAGTCAGCAAGGTTGCGTGTGTGTGTGTGTATACTCTGGCGGGTGCTG GTGTGTATGCCAGTGTTTGTTAATGTGAGCCTGTCCGCGTCCGCGTGGGTGGCCATCTGTGGTGAAGCGT CGCCGGGTCGCCGTGTGTGTACCCCCGCCTATGTCTGTCTGTCCGCGGCCGCGTGTGCGGCTGTCTGTGG CTGTGAGCCCCCGGGTCAGTGTGGGAGTGTGCGCCCCGGCGGGCGCTGGTGTGTCCCCCCTCCGAGCGGG CGGAGCACCACGTGCGGAGCCCTGGGCGCGTCGCTCTGGGGCGGAGCCAGCCCGGGGCCCCAAGCCCCAG GCCGAACCCAGGCGGGGCCCGCCCCGACCCCGCCCCCGACCCCGCCCCCAGCCCGAGCCCGCGCCGCCTG CCCAGCCCGGGAGCCCGAACAGAGCCGCGGAGCCGAGACGGCGGCGGCGCCCGTAGGATGCAGGGATCGC TCCCCCGGGGCCGCTGAGCCTGCGCCCAGTGCCCCGAGCCCCGCGCCGAGC
EPDnew 實驗支持 promoter/TSS · 2 筆
| EPDnew ID | TSS(1-based) | 股向 | 來源顯示區間 |
|---|---|---|---|
| SCN5A_2 ↗ | 3:38,649,584 | 負股 | 38,649,574–38,649,633 |
| SCN5A_1 ↗ | 3:38,649,687 | 負股 | 38,649,677–38,649,736 |
EPDnew human v006 · UCSC hg38,GRCh38/hg38,透過 UCSC 取得。TSS 具有 CAGE/RAMPAGE 等實驗資料支持;任意擷取的上下游區間仍需另行判讀調控功能,不能視為整段皆經功能驗證。
EPD 封存狀態 ↗ · UCSC 資料說明 ↗ · EPD team, SIB Swiss Institute of Bioinformatics; UCSC Genome Browser · CC BY 4.0
查看已取得的調控/motif 註解
ENSR3_835NC3 · enhancer · 38646673–38646898 · regulatory
ENSR3_5C4FN8 · CTCF_binding_site · 38646763–38646784 · regulatory
ENSR3_5C4FR2 · CTCF_binding_site · 38647361–38647382 · regulatory
ENSR3_B9N4L · enhancer · 38648946–38649676 · regulatory
ENSR3_9KC7F · promoter · 38649677–38650177 · regulatory
ENSR3_B9N4W · enhancer · 38650938–38651842 · regulatory
ENSR3_5C4GGL · CTCF_binding_site · 38651380–38651401 · regulatory
· motif · 38646765–38646781 · motif
· motif · 38647363–38647379 · motif
· motif · 38649832–38649841 · motif
· motif · 38649832–38649841 · motif
· motif · 38651382–38651398 · motif
· motif · 38651398–38651411 · motif
· motif · 38651454–38651466 · motif
· motif · 38653127–38653138 · motif
· motif · 38653131–38653145 · motif
蛋白質結構域與序列
參考蛋白質長度:2016 aa
sodium voltage-gated channel alpha subunit 5 全長 2016 個胺基酸,屬 sodium channel 家族的 Nav1.5/SCN5A 次家族。蛋白質包含四組重複的跨膜區域,每組具有 S1–S6 螺旋;大型胞質區段位於各重複單元之間及蛋白質末端,並有胞外區段連接跨膜區。這些序列註解描述其多次穿膜拓撲。
蛋白質三維結構
細胞內定位
Nav1.5 位於細胞膜,並可見於心肌細胞的肌膜與 T 小管;來源亦標示其位於細胞質周核區及細胞連結。 RANGRF 促進其運送至細胞膜。 在心臟中,Nav1.5 與 PKP2 於闰盤共定位,此項描述為相似性推論。
深綠色圓點:來源記載的蛋白質定位;數量不表示含量。
未繪示構造:Cell junction。這些構造未在通用細胞圖中標點,仍保留來源定位名稱。
動物細胞結構示意;器官大小與數量不按比例。點選細胞構造可查看定位註解。
交互作用與訊號網絡
拖曳節點後放開可帶動位置變化;點選夥伴查看證據。位置與連線長度不代表結合強度,圖中未推定夥伴彼此之間的關係。
更多交互作用夥伴 · 已取得 25 個夥伴
- APBA2Q99767 · UniProt INTERACTION · 2 experiments
- CALM3P62158 · UniProt INTERACTION · 14 experiments
- CAMK2DQ13557 · UniProt INTERACTION · 16 experiments
- DLG1Q12959 · UniProt INTERACTION · 4 experiments
- DLG2Q15700 · UniProt INTERACTION · 2 experiments
- DLG3Q92796 · UniProt INTERACTION · 2 experiments
- DLG4P78352 · UniProt INTERACTION · 3 experiments
- FGF12P61328-2 · UniProt INTERACTION · 4 experiments
- GRIP1Q9Y3R0 · UniProt INTERACTION · 5 experiments
- GRIP2Q9C0E4 · UniProt INTERACTION · 5 experiments
- IL16Q14005 · UniProt INTERACTION · 3 experiments
- LNX1Q8TBB1 · UniProt INTERACTION · 2 experiments
- LNX2Q8N448 · UniProt INTERACTION · 2 experiments
- MAGI2Q86UL8 · UniProt INTERACTION · 3 experiments
- MPDZO75970 · UniProt INTERACTION · 2 experiments
- PATJQ8NI35 · UniProt INTERACTION · 6 experiments
- PDZK1Q5T2W1 · UniProt INTERACTION · 2 experiments
- PTPN3P26045 · UniProt INTERACTION · 3 experiments
- SNTA1Q13424 · UniProt INTERACTION · 3 experiments
- WHRNQ9P202 · UniProt INTERACTION · 2 experiments
- ANKS1AQ49AR9 · UniProt INTERACTION · 3 experiments
- BANPQ8N9N5-2 · UniProt INTERACTION · 3 experiments
- EMC9Q9Y3B6 · UniProt INTERACTION · 3 experiments
- TEKT4Q8WW24 · UniProt INTERACTION · 3 experiments
- ZMYND19Q96E35 · UniProt INTERACTION · 4 experiments
SCN5A 產物與調節次單元 SCN1B 有交互作用,但依相似性資料,它與其他 Nav 通道的 β 次單元可能不具有相同的調節交互作用。它也與 syntrophin 的 PDZ domain、NEDD4、NEDD4L、WWP2、GPD1L、CALM、TMEM233、ANK3 及 PKP2 等分子互作;其中與 PKP2 的互作位於 N 端。FGF13 與其直接結合,可能調節膜上的通道密度及功能;與 FGF12、FGF14 的互作則仍屬可能。XIRP2 的互作被描述為維持正常心臟動作電位構形所需。另有與蜘蛛毒素 Jingzhaotoxin-I 的交互作用紀錄。
疾病與遺傳關聯
影響 SCN5A 的變異與多種心律及傳導疾病相關,包括 progressive familial heart block 1A、long QT syndrome 3、Brugada syndrome 1、sick sinus syndrome 1、familial paroxysmal ventricular fibrillation 1、dilated cardiomyopathy 1E 及 familial atrial fibrillation 10;相關條目將這些疾病描述為由影響此基因的變異所致。SCN5A 變異也與 sudden infant death syndrome 的易感性相關,但其致病機制仍未明。Atrial standstill 可能涉及不同遺傳位點;曾在一個大型家族中觀察到 SCN5A 變異與罕見 GJA5 基因型並存,不能據此單獨判定 SCN5A 的因果作用。
Contextual Functional Evidence Matrix
矩陣以「功能主張」為列,以細胞情境、干預條件、量測結果與證據來源為欄,方便比較同一功能在不同條件下的支持情形。只有含情境與實驗資訊的紀錄會列入矩陣;一般功能註解另列於下方。
功能註解總覽 · 13 筆
| 功能面向 | 功能敘述 | 證據類型 | 可查核來源 |
|---|---|---|---|
| 功能 | SCN5A 產物是 Nav1.5 的孔道形成次單元,直接參與興奮性細胞膜動作電位的去極化階段。通道依膜兩側電位差在開、關構形間切換;開啟時 Na(+) 沿電化學梯度選擇性通過,造成膜去極化並啟動細胞與組織間電訊號傳播。Nav1.5 是心肌細胞主要鈉通道,負責心肌動作電位初始上升相。其與 XIRP2 的交互作用則與正常心臟電傳導、心室傳導系統形成及動作電位構形有關,屬相似性描述。 | 含實驗來源 | 證據與來源Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na(+) ions provokes membrane depolarization, initiating the propagation of electrical signals throughout cells and tissues. Nav1.5 is the predominant sodium channel expressed in myocardial cells and it is responsible for the initial upstroke of the action potential in cardiac myocytes, thereby initiating the heartbeat. Required for normal electrical conduction including formation of the infranodal ventricular conduction system and normal action potential configuration, as a result of its interaction with XIRP2 (By similarity) PMID 11234013 ↗ · PMID 11804990 ↗ · PMID 12569159 ↗ · PMID 1309946 ↗ · PMID 19074138 ↗ · PMID 21447824 ↗ · PMID 23085483 ↗ · PMID 23420830 ↗ · PMID 24167619 ↗ · PMID 25370050 ↗ · PMID 26279430 ↗ · PMID 26392562 ↗ · PMID 26776555 ↗ · PMID 33712541 ↗ · PMID 40768348 ↗ |
| 分子活性 | Na(+)(in) = Na(+)(out) | 含實驗來源 | 證據與來源Na(+)(in) = Na(+)(out) PMID 11823453 ↗ · PMID 12569159 ↗ · PMID 1309946 ↗ · PMID 33712541 ↗ · PMID 40768348 ↗ |
| 交互作用 | SCN5A 產物與調節次單元 SCN1B 互作,但依相似性資料,它與其他 Nav 通道的 β 次單元可能不形成相同調節關係;也與 syntrophin 的 PDZ domain、NEDD4、NEDD4L、WWP2、GPD1L、CALM、TMEM233、ANK3 及 PKP2 互作。它與 FGF13 直接結合,FGF13 可能調節膜上通道密度與功能;與 FGF12、FGF14 的互作仍屬可能。另有與 XIRP2、蜘蛛毒素 Jingzhaotoxin-I 的互作紀錄;XIRP2 互作被描述為維持正常心臟動作電位構形所需。 | 含實驗來源 | 證據與來源Interact with regulatory subunit SCN1B. May not form the same regulatory interactions with beta subunits as other Navs do (By similarity). Interacts with the PDZ domain of the syntrophin SNTA1, SNTB1 and SNTB2 (By similarity). Interacts with NEDD4, NEDD4L, WWP2 and GPD1L. Interacts with CALM. Interacts with FGF13; the interaction is direct and FGF13 may regulate SNC5A density at membranes and function. May also interact with FGF12 and FGF14. Interacts with TMEM233. Interacts with the spider Jingzhaotoxin-I (AC P83974, AC B1P1B7, AC B1P1B8). Interacts with ANK3. Interacts with PKP2 (via N-terminus) (By similarity). Interacts with XIRP2; the interaction is required for normal action potential configuration in the heart (By similarity) PMID 15217910 ↗ · PMID 15548568 ↗ · PMID 15579534 ↗ · PMID 19666841 ↗ · PMID 21167176 ↗ · PMID 21817159 ↗ · PMID 21994374 ↗ · PMID 22705208 ↗ · PMID 25370050 ↗ · PMID 26392562 ↗ · PMID 26721415 ↗ · PMID 37117223 ↗ |
| 細胞定位 | SCN5A 產物是多次穿膜蛋白,位於細胞膜、心肌肌膜、T 小管、細胞連結及細胞質周核區。RANGRF 會促進其運送至細胞膜;在心臟闰盤處,它與 PKP2 共定位,該共定位描述依相似性資料。 | 含實驗來源 | 證據與來源Cell membrane / Multi-pass membrane protein; Cytoplasm, perinuclear region; Cell membrane, sarcolemma, T-tubule; Cell junction; RANGRF promotes trafficking to the cell membrane. Colocalizes with PKP2 at intercalated disks in the heart (By similarity) PMID 1309946 ↗ · PMID 19074138 ↗ · PMID 21447824 ↗ · PMID 23085483 ↗ · PMID 23420830 ↗ · PMID 25370050 ↗ · PMID 26279430 ↗ · PMID 33712541 ↗ · PMID 40768348 ↗ |
| 疾病關聯 | Progressive familial heart block 1A 是心臟束支傳導疾病,表現為 His-Purkinje 系統傳導逐漸改變,可有右束支傳導阻滯、左前半支傳導阻滯或兩者並存。病程可能進展至完全房室傳導阻滯,造成暈厥或猝死;此疾病被描述為由影響 SCN5A 的變異所致。 | 含實驗來源 | 證據與來源Progressive familial heart block 1A PFHB1A A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death. The disease is caused by variants affecting the gene represented in this entry MIM: 113900 PMID 11234013 ↗ · PMID 11804990 ↗ · PMID 12569159 ↗ · PMID 12574143 ↗ · PMID 19251209 ↗ · PMID 23420830 ↗ |
| 疾病關聯 | Long QT syndrome 3 的特徵是心電圖 QT 間期延長及多形性心室心律不整,可能在運動或情緒壓力下引發暈厥與猝死,也可能以嬰兒期猝死作為最早事件。此疾病被描述為由影響 SCN5A 的變異所致。 | 含實驗來源 | 證據與來源Long QT syndrome 3 LQT3 A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. The disease is caused by variants affecting the gene represented in this entry MIM: 603830 PMID 10377081 ↗ · PMID 10508990 ↗ · PMID 10590249 ↗ · PMID 10627139 ↗ · PMID 10911008 ↗ · PMID 10973849 ↗ · PMID 11304498 ↗ · PMID 11410597 ↗ · PMID 11535573 ↗ · PMID 11710892 ↗ · PMID 11889015 ↗ · PMID 11997281 ↗ · PMID 12209021 ↗ · PMID 12454206 ↗ · PMID 12673799 ↗ · PMID 15840476 ↗ · PMID 16414944 ↗ · PMID 16922724 ↗ · PMID 18060054 ↗ · PMID 18378609 ↗ · PMID 18451998 ↗ · PMID 18708744 ↗ · PMID 18848812 ↗ · PMID 18929331 ↗ · PMID 19027780 ↗ · PMID 19716085 ↗ · PMID 26392562 ↗ · PMID 7651517 ↗ · PMID 7889574 ↗ · PMID 8541846 ↗ |
| 疾病關聯 | Brugada syndrome 1 是心搏過速性心律不整,心電圖特徵包括右束支傳導阻滯及 ST 節段上升。心室可能快速跳動而使全身血液循環效率降低,患者可能昏厥;若心律未及時恢復,可能在數分鐘內死亡。此疾病被描述為由影響 SCN5A 的變異所致。 | 含實驗來源 | 證據與來源Brugada syndrome 1 BRGDA1 A tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. The disease is caused by variants affecting the gene represented in this entry MIM: 601144 PMID 10532948 ↗ · PMID 10618304 ↗ · PMID 10690282 ↗ · PMID 11410597 ↗ · PMID 11748104 ↗ · PMID 11823453 ↗ · PMID 11901046 ↗ · PMID 12051963 ↗ · PMID 12106943 ↗ · PMID 15023552 ↗ · PMID 15338453 ↗ · PMID 15579534 ↗ · PMID 15851320 ↗ · PMID 16266370 ↗ · PMID 16325048 ↗ · PMID 16616735 ↗ · PMID 17075016 ↗ · PMID 17081365 ↗ · PMID 17198989 ↗ · PMID 18252757 ↗ · PMID 18341814 ↗ · PMID 18451998 ↗ · PMID 18456723 ↗ · PMID 18616619 ↗ · PMID 19027780 ↗ · PMID 19251209 ↗ · PMID 19272188 ↗ · PMID 20129283 ↗ · PMID 23085483 ↗ · PMID 23420830 ↗ |
| 疾病關聯 | Sick sinus syndrome 1 涵蓋由竇房結功能異常造成的多種狀況,常見暈厥、近乎暈厥、頭暈與疲倦;心電圖可見竇性心搏過緩、竇性停搏或竇房阻滯,也可能有心房心搏過速與心搏過緩交替。此類症候群常見於年長且有心臟病或曾接受心臟手術者,也可能出現在無其他相關因素的胎兒、嬰兒或兒童;此亞型可於胎內、嬰兒期或幼兒早期發病。疾病被描述為由影響 SCN5A 的變異所致。 | 含實驗來源 | 證據與來源Sick sinus syndrome 1 SSS1 The term 'sick sinus syndrome' encompasses a variety of conditions caused by sinus node dysfunction. The most common clinical manifestations are syncope, presyncope, dizziness, and fatigue. Electrocardiogram typically shows sinus bradycardia, sinus arrest, and/or sinoatrial block. Episodes of atrial tachycardias coexisting with sinus bradycardia ('tachycardia-bradycardia syndrome') are also common in this disorder. SSS occurs most often in the elderly associated with underlying heart disease or previous cardiac surgery, but can also occur in the fetus, infant, or child without heart disease or other contributing factors. SSS1 onset is in utero, infancy, or early childhood. The disease is caused by variants affecting the gene represented in this entry MIM: 608567 PMID 11748104 ↗ · PMID 14523039 ↗ · PMID 22795782 ↗ |
| 疾病關聯 | Familial paroxysmal ventricular fibrillation 1 是一種心律不整,特徵為心肌纖維快速反覆興奮,造成心室肌纖維顫動而無法協調收縮,並伴隨心房活動缺失。此疾病被描述為由影響 SCN5A 的變異所致。 | 含實驗來源 | 證據與來源Familial paroxysmal ventricular fibrillation 1 VF1 A cardiac arrhythmia marked by fibrillary contractions of the ventricular muscle due to rapid repetitive excitation of myocardial fibers without coordinated contraction of the ventricle and by absence of atrial activity. The disease is caused by variants affecting the gene represented in this entry MIM: 603829 PMID 10940383 ↗ |
| 疾病關聯 | Sudden infant death syndrome 指未滿一歲嬰兒經完整個案調查後仍無法解釋的猝死,調查包括完整解剖、死亡現場檢查及臨床病史回顧。可能涉及呼吸功能異常、心律不整、心肺不穩定或先天代謝異常,但導致嬰兒猝死的確切病理機制仍未明。此疾病易感性與影響 SCN5A 的變異相關,而非在此描述為確定因果。 | 含實驗來源 | 證據與來源Sudden infant death syndrome SIDS SIDS is the sudden death of an infant younger than 1 year that remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of clinical history. Pathophysiologic mechanisms for SIDS may include respiratory dysfunction, cardiac dysrhythmias, cardiorespiratory instability, and inborn errors of metabolism, but definitive pathogenic mechanisms precipitating an infant sudden death remain elusive. Disease susceptibility is associated with variants affecting the gene represented in this entry MIM: 272120 PMID 18596570 ↗ · PMID 19302788 ↗ |
| 疾病關聯 | Atrial standstill 1 是罕見心律不整,心房缺乏電氣與機械活動;心電圖可呈現心搏過緩、P 波消失及交界性窄 QRS 逸搏節律。疾病可能由不同遺傳位點的變異造成,包括 SCN5A。曾在一個大型家族中發現 SCN5A 變異與罕見 GJA5 基因型並存,不能由此單獨確定 SCN5A 的因果角色。 | 含實驗來源 | 證據與來源Atrial standstill 1 ATRST1 A rare arrhythmia characterized by the absence of electrical and mechanical activity in the atria. Electrocardiographically, it is characterized by bradycardia, the absence of P waves, and a junctional narrow complex escape rhythm. The disease may be caused by variants affecting distinct genetic loci, including the gene represented in this entry. A mutation in SCN5A has been detected in combination with a rare GJA5 genotype in a large family with atrial standstill MIM: 108770 PMID 12522116 ↗ · PMID 23420830 ↗ |
| 疾病關聯 | Dilated cardiomyopathy 1E 的特徵是心室擴大與收縮功能受損,可導致充血性心衰竭及心律不整,患者有早逝風險。此疾病被描述為由影響 SCN5A 的變異所致。 | 含實驗來源 | 證據與來源Cardiomyopathy, dilated, 1E CMD1E A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. The disease is caused by variants affecting the gene represented in this entry MIM: 601154 PMID 15466643 ↗ · PMID 23420830 ↗ |
| 疾病關聯 | Familial atrial fibrillation 10 是心房顫動的家族型態;心房電活動紊亂且收縮無效,促使血液滯留心房並減少心室充盈。可能出現心悸、暈厥、血栓栓塞性中風及充血性心衰竭。此疾病被描述為由影響 SCN5A 的變異所致。 | 含實驗來源 | 證據與來源Atrial fibrillation, familial, 10 ATFB10 A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. The disease is caused by variants affecting the gene represented in this entry MIM: 614022 PMID 18088563 ↗ · PMID 18378609 ↗ |
核酸與蛋白質序列
AGAGCCGCGGAGCCGAGACGGCGGCGGCGCCCGTAGGATG40CAGGGATCGCTCCCCCGGGGCCGCTGAGCCTGCGCCCAGT80GCCCCGAGCCCCGCGCCGAGCCGAGTCCGCGCCAAGCAGC120AGCCGCCCACCCCGGGGCCCGGCCGGGGGACCAGCAGCTT160CCCCACAGGCAACGTGAGGAGAGCCTGTGCCCAGAAGCAG200GATGAGAAGATGGCAAACTTCCTATTACCTCGGGGCACCA240GCAGCTTCCGCAGGTTCACACGGGAGTCCCTGGCAGCCAT280CGAGAAGCGCATGGCAGAGAAGCAAGCCCGCGGCTCAACC320ACCTTGCAGGAGAGCCGAGAGGGGCTGCCCGAGGAGGAGG360CTCCCCGGCCCCAGCTGGACCTGCAGGCCTCCAAAAAGCT400GCCAGATCTCTATGGCAATCCACCCCAAGAGCTCATCGGA440GAGCCCCTGGAGGACCTGGACCCCTTCTATAGCACCCAAA480AGACTTTCATCGTACTGAATAAAGGCAAGACCATCTTCCG520GTTCAGTGCCACCAACGCCTTGTATGTCCTCAGTCCCTTC560CACCCCATCCGGAGAGCGGCTGTGAAGATTCTGGTTCACT600CGCTCTTCAACATGCTCATCATGTGCACCATCCTCACCAA640CTGCGTGTTCATGGCCCAGCACGACCCTCCACCCTGGACC680AAGTATGTCGAGTACACCTTCACCGCCATTTACACCTTTG720AGTCTCTGGTCAAGATTCTGGCTCGAGGCTTCTGCCTGCA760CGCGTTCACTTTCCTTCGGGACCCATGGAACTGGCTGGAC800TTTAGTGTGATTATCATGGCATACACAACTGAATTTGTGG840ACCTGGGCAATGTCTCAGCCTTACGCACCTTCCGAGTCCT880CCGGGCCCTGAAAACTATATCAGTCATTTCAGGGCTGAAG920ACCATCGTGGGGGCCCTGATCCAGTCTGTGAAGAAGCTGG960cDNA 使用 DNA 字母 T;mRNA 模式改以 U 顯示。轉錄本保留已註解的非編碼區,未另外加入 poly(A) 尾;非編碼 RNA 的參考轉錄本也可能仍需後續加工。數字為所選序列的 1-based 位置。長序列以黃色捲軸瀏覽,可複製或下載完整轉錄本與蛋白質;基因組 DNA 隨捲動取得所需範圍。